X-Ceptor Therapeutics' Acquisition

X-Ceptor Therapeutics was acquired by Exelixis on October 19, 2004.

X-Ceptor Therapeutics specializes in drug development focused on orphan nuclear receptors.…

Articles about X-Ceptor Therapeutics' Acquisition: